Compositions and Soft Tissue Replacement Methods
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 12 of these applications claim priority to application 61/375,144, filed Aug 19, 2010. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 8,518,396 | Compositions and Methods for Soft Tissue Replacement In force · High confidence | Allergan, Inc. | In force | High confidence | ||
| US 8,697,056 | Compositions and Soft Tissue Replacement Methods In force · High confidence | Allergan, Inc. | In force | High confidence | ||
| US 8,697,057 | Compositions and Soft Tissue Replacement Methods In force · High confidence | Allergan, Inc. | In force | High confidence | ||
| US 8,697,059 | Compositions and Soft Tissue Replacement Methods In force · High confidence | Allergan, Inc. | In force | High confidence | ||
| US 8,741,281 | Compositions and Soft Tissue Replacement Methods In force · High confidence | Allergan, Inc. | In force | High confidence | ||
| US 8,926,963 | Compositions and Soft Tissue Replacement Methods In force · High confidence | Allergan, Inc. | In force | High confidence | ||
| US 9,005,605 | Compositions and Soft Tissue Replacement Methods In force · Medium confidence | Allergan, Inc. | In force | Medium confidence | ||
| US 9,334,262 | Methods of Treating Soft Tissue Defects In force · High confidence | Allergan, Inc. | In force | High confidence | ||
| US 8,889,123 | Compositions and Soft Tissue Replacement Methods In force · High confidence | Allergan, Inc. | In force | High confidence | ||
| US 8,900,571 | Compositions and Soft Tissue Replacement Methods In force · High confidence | Allergan, Inc. | In force | High confidence | ||
| 3 more patents in this group · Pro | ||||||
10 of 13 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Pro members see all 13.
12 of these are in force and held by Allergan, Inc..
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.